CopyMark Law Group
4.9/5
Drawing for BICE

USPTO serial 97119537

BICE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KHAN, AHSEN M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BICE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Fingerhut

Eric Fingerhut DYKEMA GOSSETT PLLC1301 K STREET, N.W.SUITE 1100 WESTWASHINGTON, DC 20005

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical, biological and biotechnical preparations, namely, antibodies, bi- and multispecific antibodies and fragments thereof, in the nature of monoclonal antibodies, their derivatives or conjugates for in vivo or in vitro scientific and industrial research and development related to diseases; active chemical ingredients for use in the manufacture of pharmaceutical preparations for treating cancer, infectious diseases, and autoimmune diseasesACTIVE—
005Pharmaceutical and veterinary preparations that contain antibodies, and bi- and multi-specific antibodies and fragments, including monoclonal antibodies, their derivatives or conjugates, for use to treat cancer, infectious diseases, and autoimmune diseasesACTIVE—
042Medical and biological research, in particular research into antibodies and bi- and multispecific antibodies or fragments, including monoclonal antibodies, their derivatives or conjugates, and the development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monoclonal antibodies, their derivatives or conjugates; Chemical analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 2, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 1, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 30, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 26, 2023EX1GSOU EXTENSION 1 GRANTED—
May 26, 2023EXT1SOU EXTENSION 1 FILED—
May 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 4, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 4, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 14, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 1, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022DOCKASSIGNED TO EXAMINER—
Nov 18, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance